Latest Quality Control News

Lark Distilling Co. Ltd grew net sales by 15% in FY26, driven by whisky and international expansion, but posted a $40 million loss after goodwill and inventory impairments.

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

Corporate Travel Management (ASX:CTD) has locked in a five-year global partnership with Amadeus IT Group, aiming to accelerate its digital transformation and operational efficiency across multiple regions.

Toubani Resources reports robust high-grade gold intersections from pre-production drilling at its Kobada Gold Project, triggering a Mineral Resource Estimate update and advancing development plans toward mining in early 2027.

Broken Hill Mines (ASX: BHM) has delivered a suite of high-grade silver, lead, zinc, copper, and gold intercepts from recent drilling at its Pinnacles Mine open pit area, underpinning ongoing mining operations and a planned resource upgrade by year-end.

The Calmer Co. has secured a long-term supply agreement for premium noble kava from Papua New Guinea and Vanuatu, underpinning its manufacturing growth and diversified Pacific sourcing network.

Pantoro Gold’s latest infill drilling at Racetrack within the Norseman Project reveals exceptional high-grade continuity, including a spectacular 1,737 g/t gold intercept, underpinning plans to ramp up underground production.

Gibb River Diamonds has reported Phase 2 drilling results from its Edjudina Gold Project, highlighting a standout 7.80 g/t gold intercept that aligns with previous high-grade findings at the new West Gawler prospect.

Azzuro Resources' 3D gravity inversion at Red Hill uncovers a continuous high-density body extending well below existing drill levels, highlighting new down-plunge and southwest targets for imminent drilling.

Azzuro Resources has locked in a major copper-gold discovery at its newly acquired Red Hill project in Mongolia, confirming a high-grade VMS system over nearly 550 metres of strike with significant expansion potential.

Caspin Resources has delivered new high-grade tin results from the Kelpie Deposit, including a standout 3m intercept at 9.32% tin, extending mineralisation beyond the current resource and pointing to significant growth potential.

AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.